CFM
EGRX

Catalyst Funds Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Catalyst Funds Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10
Closed -$52 – 1687
2024
Q1 		$52 Buy
+10
New +$52 ﹤0.01% 1088